Filters
Results 1 - 10 of 3418
Results 1 - 10 of 3418.
Search took: 0.032 seconds
Sort by: date | relevance |
Baltas, D.; Geramani, K.N.; Ioannidis, G.T.; Kolotas, C.; Zamboglou, N.; Giannouli, S.
Proceedings of the 8. Mediterranean Conference on Medical and Biological Engineering and Computing (Medicon '98)1998
Proceedings of the 8. Mediterranean Conference on Medical and Biological Engineering and Computing (Medicon '98)1998
AbstractAbstract
[en] Source anisotropy is a very important factor in brachytherapy quality assurance of high dose rate HDR Ir 192 afterloading stepping sources. If anisotropy is not taken into account then doses received by a brachytherapy patient in certain directions can be in error by a clinically significant amount. Experimental measurements of anisotropy are very labour intensive. We have shown that within acceptable limits of accuracy, Monte Carlo integration (MCI) of a modified Sievert integral (3D generalisation) can provide the necessary data within a much shorter time scale than can experiments. Hence MCI can be used for routine quality assurance schedules whenever a new design of HDR or PDR Ir 192 is used for brachytherapy afterloading. Our MCI calculation results are comparable with published experimental data and Monte Carlo simulation data for microSelectron and VariSource Ir 192 sources. We have shown not only that MCI offers advantages over alternative numerical integration methods, but also that treating filtration coefficients as radial distance-dependent functions improves Sievert integral accuracy at low energies. This paper also provides anisotropy data for three new Ir 192 sources, one for microSelectron-HDR and two for the microSelectron-PDR, for which data currently is not available. The information we have obtained in this study can be incorporated into clinical practice
Primary Subject
Source
Christofides, Stelios; Pattichis, Constantinos; Schizas, Christos; Keravnou-Papailiou, Elpida; Kaplanis, Prodromos; Spyros, Spyrou; Christodoulides, George; Theodoulou, Yiannis (eds.); Cyprus Association of Medical Physics and Biomedical Engineering (CAMPBE), Nicosia (Cyprus); The Department of Computer Science, University of Cyprus, Nicosia (Cyprus); 220 p; ISBN 9963-607-14-4;
; 1998; p. 131; 8. Mediterranean Conference on Medical and Biological Engineering and Computing (Medicon '98); Lemesos (Cyprus); 14-17 Jun 1998

Record Type
Miscellaneous
Literature Type
Conference
Report Number
Country of publication
BETA DECAY RADIOISOTOPES, BETA-MINUS DECAY RADIOISOTOPES, CALCULATION METHODS, DAYS LIVING RADIOISOTOPES, ELECTRON CAPTURE RADIOISOTOPES, HEAVY NUCLEI, IMPLANTS, INTERNAL CONVERSION RADIOISOTOPES, IRIDIUM ISOTOPES, ISOMERIC TRANSITION ISOTOPES, ISOTOPES, MINUTES LIVING RADIOISOTOPES, NUCLEI, ODD-ODD NUCLEI, RADIATION SOURCES, RADIOISOTOPES, YEARS LIVING RADIOISOTOPES
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
Vega C, H.R.; Torres M, C.
Proceedings of the 1st Ibero-Latin American and Caribbean Congress on Medical Physics. Mexico 981998
Proceedings of the 1st Ibero-Latin American and Caribbean Congress on Medical Physics. Mexico 981998
AbstractAbstract
[en] The Synovectomy by Neutron capture has as purpose the treatment of the rheumatoid arthritis, illness which at present does not have a definitive curing. This therapy requires a neutron source for irradiating the articulation affected. The energy spectra and the intensity of these neutrons are fundamental since these neutrons induce nuclear reactions of capture with Boron-10 inside the articulation and the freely energy of these reactions is transferred at the productive tissue of synovial liquid, annihilating it. In this work it is presented the neutron spectra results obtained with moderator packings of spherical geometry which contains in its center a Pu239 Be source. The calculations were realized through Monte Carlo method. The moderators assayed were light water, heavy water base and the both combination of them. The spectra obtained, the average energy, the neutron total number by neutron emitted by source, the thermal neutron percentage and the dose equivalent allow us to suggest that the moderator packing more adequate is what has a light water thickness 0.5 cm (radius 2 cm) and 24.5 cm heavy water (radius 26.5 cm). (Author)
Original Title
Sinovectomia por captura de neutrones
Primary Subject
Source
Gaona, E. (ed.) (Universidad Autonoma Metropolitana, Mexico D.F. (Mexico)); Huitron, B.G. (ed.) (Universidad Autonoma del Estado de Mexico, Toluca (Mexico)); Asociacion Latinoamericana de Fisica Medica (ALFIM) (Mexico); Sociedad Espanola de Fisica Medica (SEFM) (Spain); Secretaria de Salud de Mexico (Mexico); Instituto Nacional de Cancerologia (Mexico); Organismo Internacional de Energia Atomica (IAEA), Vienna (Austria); Organizacion Panamericana de la Salud (Mexico); Organizacion Internacional de Fisica Medica (Mexico); Universidad Autonoma Metropolitana (Mexico); Instituto Nacional de Investigaciones Nucleares (Mexico); Universidad Autonoma del Estado de Mexico (Mexico); Universidad Nacional Autonoma de Mexico (Mexico); Direccion de Riesgos Radiologicos (Mexico); Comision Nacional de Seguridad Nuclear y Salvaguardias (Mexico); Sociedad Mexicana de Radioterapeutas, A.C. (Mexico); Centro de Investigacion y Estudios Avanzados, IPN (Mexico); Centro Universitario contra el Cancer, UANL (Mexico); Asociacion Mexicana de Fisica Medica, A.C. (Mexico); Sociedad de Fisica Medica de Nuevo Leon, A.C. (Mexico); Sociedades Nacionales de Fisica Medica de Latinoamerica y el Caribe (Mexico). Funding organisation: Med-Tec (United States); Nucletron (Mexico); Grupo Venta Internacional, S.A. de C.V. (Leibinger) (Mexico); PTW Freiburg (Germany); Scanditronix Medical AB (Mexico); Kodak (United States); Electronica y Medicina, S.A. (Mexico); Siemens (Germany); Electronica 2000, S.A. de C.V. (Mexico); 283 p; ISBN 968-835-419-8;
; 1998; p. 254-257; 1. Ibero-Latin American and Caribbean Congress on Medical Physics; 1. Congreso Iberolatinoamericano y del Caribe de Fisica Medica; Mexico, D.F. (Mexico); 22-25 Nov 1998

Record Type
Miscellaneous
Literature Type
Conference
Report Number
Country of publication
ACTINIDE NUCLEI, ALKALINE EARTH METALS, ALPHA DECAY RADIOISOTOPES, BETA DECAY RADIOISOTOPES, BODY, BORON ISOTOPES, CALCULATION METHODS, DEUTERIUM COMPOUNDS, ELECTRON CAPTURE RADIOISOTOPES, ELEMENTS, ENERGY RANGE, EVEN-ODD NUCLEI, HEAVY NUCLEI, HYDROGEN COMPOUNDS, INTERNAL CONVERSION RADIOISOTOPES, ISOTOPES, LIGHT NUCLEI, MEDICINE, METALS, MINUTES LIVING RADIOISOTOPES, NEUTRON THERAPY, NUCLEI, ODD-ODD NUCLEI, ORGANS, OXYGEN COMPOUNDS, PLUTONIUM ISOTOPES, RADIOISOTOPES, RADIOTHERAPY, SKELETON, SPONTANEOUS FISSION RADIOISOTOPES, STABLE ISOTOPES, THERAPY, WATER
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] The objective of quantitative imaging is to Provide pharmacokinetic information for patients that is analogous to that provided by biodistribution studies in mice. Radio nuclide images depict the distribution of labeled antibodies in-vivo; thus the amount of radio nuclide in a specific organ or site can be estimated by relating the counts detected in a defined region of interest to the total radio nuclide content. This pharmacokinetic information can be used to obtain definitive and relevant answers to basic questions of importance for optimizing radioimmunoimaging and radioimmunotherapy and, in addition, can provide a data base from which to calculate the distribution of radiation absorbed doses. The projects supported by this program routinely employ quantitative imaging in evaluating therapies. Quantitative imaging is performed by a certified nuclear medicine technician using the Siemens gamma camera interfaced with the microVAX II. The technician processes the imaging data and obtains pharmacokinetic information from it using programs developed by us and others. During this grant period project staff have acquired and analyzed a large amount of data on the pharmacokinetics, dosimetry and toxicity of radiolabeled monoclonal therapy. Important dosimetry data on the whole body, marrow and tumor doses are available and all studies are archived so that they can be retrospectively analyzed
Primary Subject
Secondary Subject
Source
1998; 9 p; CONTRACT FG03-84ER60233; ALSO AVAILABLE FROM OSTI AS DE98005070; NTIS; US GOVT. PRINTING OFFICE DEP
Record Type
Report
Report Number
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Pusuwan, P.; Chaiwatanarat, T.; Chaudakshetrin, P.
Proceedings of the 6th nuclear science and technology conference1996
Proceedings of the 6th nuclear science and technology conference1996
AbstractAbstract
[en] Samarium-153 ethylenediamine-tetra methylene phosphonate (153 Sm-EDTMP) has been proposed as a radionuclide therapeutic agent to palliate pain resulting from osteoblastic metastatic bone cancer. Six patients with disseminated skeletal metastases from a variety of tumor types underwent clinical trial of this agent obtained from the Office of Atomic Energy for Peace (OAEP), Thailand. All of the patients received 1 mCi/kg of 153 Sm-EDTMP intravenously. The preferential localization of 153 Sm-EDTMP in bony lesions was assessed and compared to the routine bone seeking agent, 99mTc-MDP. Both radiopharmaceuticals showed similar uptake in lesional and nonlesional bone (p < 0.001). The retained skeletal activity varied from 56.54% to 76.23% of the administered dose and greater than 91% ± 6.77% of the non osseous activity was cleared in the urine within 6 hours in all patients. Fifty percents of the patients developed a transient exacerbation of their pre-153 Sm-EDTMP pain and lasted within 1-2 weeks. The other patients lost follow up. This study indicates potential for 153 Sm-EDTMP as a therapeutic radiopharmaceutical for pain palliation of cancer bone metastases
Primary Subject
Source
Office of Atomic Energy for Peace, Bangkok (Thailand); 761 p; Dec 1996; [9 p.]; 6. Conference on Nuclear Science and Technology; Bangkok (Thailand); 2-4 Dec 1996; ALSO AVAILABLE FROM OFFICE OF ATOMIC ENERGY FOR PEACE, BANGKOK (THAILAND)
Record Type
Miscellaneous
Literature Type
Conference; Numerical Data
Report Number
Country of publication
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
Asghar, S.; Sajjad, R.; Ilyas, N.
International seminar on therapeutic applications of radiopharmaceuticals. Programme. Book of extended synopses1998
International seminar on therapeutic applications of radiopharmaceuticals. Programme. Book of extended synopses1998
AbstractAbstract
No abstract available
Primary Subject
Source
International Atomic Energy Agency, Vienna (Austria); 194 p; Dec 1998; p. 56; International seminar on therapeutic applications of radiopharmaceuticals; Hyderabad (India); 18-22 Jan 1999; IAEA-SR--209/39
Record Type
Miscellaneous
Literature Type
Conference
Report Number
Country of publication
ANIMALS, BETA DECAY RADIOISOTOPES, BETA-MINUS DECAY RADIOISOTOPES, BODY, DAYS LIVING RADIOISOTOPES, DISEASES, ENDOCRINE GLANDS, GLANDS, INTERMEDIATE MASS NUCLEI, IODINE ISOTOPES, IRRADIATION, ISOTOPES, MAMMALS, MAN, MEDICINE, NEOPLASMS, NUCLEI, ODD-EVEN NUCLEI, ORGANS, PRIMATES, RADIATION EFFECTS, RADIOISOTOPES, THERAPY, VERTEBRATES
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
Pusuwan, P.; Chaudakshetrin, P.; Na Songkhla, S.; Asavatanabodee, P.; Virawat, N.
International seminar on therapeutic applications of radiopharmaceuticals. Programme. Book of extended synopses1998
International seminar on therapeutic applications of radiopharmaceuticals. Programme. Book of extended synopses1998
AbstractAbstract
No abstract available
Primary Subject
Source
International Atomic Energy Agency, Vienna (Austria); 194 p; Dec 1998; p. 150-152; International seminar on therapeutic applications of radiopharmaceuticals; Hyderabad (India); 18-22 Jan 1999; IAEA-SR--209/52; 2 refs, 1 fig., 1 tab
Record Type
Miscellaneous
Literature Type
Conference
Report Number
Country of publication
BETA DECAY RADIOISOTOPES, BETA-MINUS DECAY RADIOISOTOPES, BODY, COUNTING TECHNIQUES, DAYS LIVING RADIOISOTOPES, DIAGNOSTIC TECHNIQUES, DISEASES, DRUGS, EVEN-ODD NUCLEI, INTERMEDIATE MASS NUCLEI, ISOTOPES, LABELLED COMPOUNDS, MATERIALS, MEDICINE, MINERALS, NUCLEI, ORGANS, PHOSPHATE MINERALS, RADIOACTIVE MATERIALS, RADIOISOTOPE SCANNING, RADIOISOTOPES, RARE EARTH NUCLEI, SAMARIUM ISOTOPES, SKELETAL DISEASES, SKELETON, THERAPY
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
Glukhovskaya, I.Yu.; Yugrinov, O.G.; Demin, V.T.; Kobys', V.L.
Radiation diagnosis, radiation therapy. Collection of the scientific research in association of radiologists of Ukraine1997
Radiation diagnosis, radiation therapy. Collection of the scientific research in association of radiologists of Ukraine1997
AbstractAbstract
No abstract available
Original Title
Ispol'zovanie pentoksifillina v kachestve modifikatora tsisplatina pri vnutriarterial'noj khimioterapii zlokachestvennykh opukholej kostej i myagkikh tkanej u detej
Primary Subject
Source
Babyij, Ya.S. (ed.); Ministerstvo Zdravookhraneniya Ukrainskoj SSR, Kiev (Ukraine); Nauchno-Issledovatel'skij Rentgeno-Radiologicheskij i Onkologicheskij Inst., Kiev (Ukraine); Khar'kovskij Nauchno-Issledovatel'skij Inst. Meditsinskoj Radiologii, Kharkov (Ukraine); Asotsyiatsyiya radyiologyiv Ukrayini, Kyiv (Ukraine); Naukovo-Tekhnyichnij zbyirnik; v. 1; 140 p; ISBN 966-95116-3-1;
; 1997; p. 18-19; Meditsina Ukrayini; Kyiv (Ukraine); Republican scientific and practical conference on radiation diagnosis and radiation therapy; Respublyikans'ka naukovo-praktichna konferentsyiya: promeneva dyiagnostika, promeneva terapyiya; Kharkov (Ukraine); 17-18 Sep 1997

Record Type
Miscellaneous
Literature Type
Conference
Report Number
Country of publication
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Since 1989, an international collaboration group, with support from the European Commission and from numerous national grant agencies, has been working to establish boron neutron capture therapy (BNCT) with epithermal neutrons as an alternative therapy for high-grade glioma. A total of 15 European countries are working toward this goal
Primary Subject
Source
Winter meeting of the American Nuclear Society (ANS); San Francisco, CA (United States); 29 Oct - 1 Nov 1995; CONF-951006--
Record Type
Journal Article
Literature Type
Conference
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Neutron capture therapy (NCT) is a binary therapeutic modality with significant potential for the treatment of localized tumors in humans. The NCT relies on selective uptake and/or retention within tumor of a nontoxic neutron capture agent (NCA) containing a neutron capture element such as 10B and irradiation of the tumor with an appropriate-energy neutron beam. The development of tumor-affinative capture agents is requisite for efficacious NCT, particularly those NCAs that specifically localize to vital organelles such as mitochondria and nuclei. Various methods have been utilized to determine tumor and normal tissue boron levels. Few, however, have successfully localized neutron capture elements, in vivo, at the ultrastructural level, which is crucial for determination of radiation microdosimetry. This paper describes experimental results of NCT on gliosarcomas in rats
Primary Subject
Source
Winter meeting of the American Nuclear Society (ANS); San Francisco, CA (United States); 29 Oct - 1 Nov 1995; CONF-951006--
Record Type
Journal Article
Literature Type
Conference
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] The paper deals with a study of methods to improve the efficiency of combined treatment of oncological patients with a not quite favourable forecast. Radiation therapy methods producing a systematic antitumor effect are proposed. The systematic radiation therapy (SRT) is aimed at producing a tumoricidal effect on multiple obvious subclinical and occult tumor centers. The perspectives of SRT development include the expansion of radiobiological investigations in the clinic, which investigations will enable a more comprehensive idea of the mechanism of SRT action
Original Title
Tekhnologicheskie podkhody k sistemnoj luchevoj terapii onkologicheskikh bol'nykh
Primary Subject
Record Type
Journal Article
Journal
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
1 | 2 | 3 | Next |